<DOC>
<DOCNO>
EP-0007467
</DOCNO>
<TEXT>
<DATE>
19800206
</DATE>
<IPC-CLASSIFICATIONS>
<main>A61K-39/145</main> A61K-39/145 
</IPC-CLASSIFICATIONS>
<TITLE>
anti-influenza vaccine and process for its preparation.
</TITLE>
<APPLICANT>
smith kline rit be<sep>societe anonyme dite: smith kline - rit<sep>smith kline - rit société anonyme dite:rue du tilleul, 13b-1320 genval (rixensart)be<sep>smith kline - rit societe anonyme dite:<sep>
</APPLICANT>
<INVENTOR>
florent gerard<sep>lobmann michele<sep>florent, gerard<sep>lobmann, michele<sep>florent, gérardchamp du cygne, 13b-1320 genval (rixensart)be<sep>löbmann, michèlerue d'angoussart, 165b-1301 bierges (wavre)be<sep>florent, gerard<sep>lobmann, michele <sep>florent, gérard champ du cygne, 13 b-1320 genval (rixensart)be<sep>löbmann, michèlerue d'angoussart, 165b-1301 bierges (wavre)be<sep>
</INVENTOR>
<ABSTRACT>
The invention relates to a new influenza vaccine and its preparation.The vaccine contains a new strain of recombination prepared virus between influenza A / Pr / 8/34 and A / Alaska / 5/77 virus strains (C. c. m. I-063).It is called RIT 4199 (c. c. m. I-062).The vaccine is prepared by culture of the virus strain c.not.vs.m.I-062 in the allantoídian cavity of embryied chicken eggs, harvesting and freeze-dried virus produced.The strain of the virus and the drifting vaccine are used in the prevention of influenza.
</ABSTRACT>
</TEXT>
</DOC>
